Should We Measure Quality by the Dose?

This publication has 15 references indexed in Scilit:

• Treatments, Trends, and Outcomes of Acute Myocardial Infarction and Percutaneous Coronary Intervention
  JACC, 2010
• Regional and Practice Variation in Adherence to Guideline Recommendations for Secondary and Primary Prevention Among Outpatients With Atherothrombosis or Risk Factors in the United States
  Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2009
• An Organized Approach to Improvement in Guideline Adherence for Acute Myocardial Infarction
  Archives of internal medicine (1960), 2008
• International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis
  JAMA, 2006
• Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
  JAMA, 2004
• Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
  The Lancet, 2003
• Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE)
  European Heart Journal, 2002
• Improving Quality of Care for Acute Myocardial InfarctionThe Guidelines Applied in Practice (GAP) Initiative
  JAMA, 2002
• Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)
  The American Journal of Cardiology, 2001
• Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction
  Circulation, 2001